UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples